Murray K T, Hu N N, Daw J R, Shin H G, Watson M T, Mashburn A B, George A L
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn. 37232-6602, USA.
Circ Res. 1997 Mar;80(3):370-6. doi: 10.1161/01.res.80.3.370.
The cardiac Na+ current plays an important role in determining normal and abnormal impulse propagation in the heart. We have investigated the effects of protein kinase C (PKC) activation on the recombinant human cardiac Na+ channel (hH1) following heterologous expression in Xenopus laevis oocytes. Phorbol 12-myristate 13-acetate (PMA), which directly activates PKC, reduced current amplitude at all test potentials (43 +/- 12% at -10 mV). In contrast to the rat brain IIA (rBIIA) channel, there was no apparent change in either macroscopic Na+ current decay or the voltage dependence of channel gating. Further experiments indicate that the effects of PMA were mediated by PKC activation: (1) an inactive stereoisomer, 4 alpha-PMA, had no effect; (2) preincubation with the protein kinase inhibitor chelerythrine prevented the PMA effects; and (3) a hydrolyzable diacylglycerol analogue, 1-oleoyl-2-acetyl-glycerol, also reduced current (22 +/- 5%). In addition, when the alpha 1B-adrenergic receptor was coexpressed with hH1, the alpha-receptor agonist methoxamine reduced hH1 current (45 +/- 10%), an effect that could be eliminated by chelerythrine preincubation. When a conserved consensus PKC site (serine 1503) in the III-IV interdomain linker thought to be responsible for the PKC effects on rBIIA was mutated, PMA still reduced Na+ current, but the magnitude of the effect was smaller compared with that for the wild-type channel. Similar findings were obtained with alpha 1-receptor stimulation following receptor coexpression with the mutant channel. We conclude that activation of PKC modulates the human cardiac Na+ channel by at least two mechanisms, one similar to that seen with rat brain channels, involving a conserved putative PKC site, and a second more specific to the cardiac isoform.
心脏钠电流在决定心脏正常和异常冲动传导中起重要作用。我们研究了蛋白激酶C(PKC)激活对在非洲爪蟾卵母细胞中异源表达的重组人心脏钠通道(hH1)的影响。直接激活PKC的佛波酯12 -肉豆蔻酸酯13 -乙酸酯(PMA)在所有测试电位下均降低电流幅度(在 -10 mV时为43±12%)。与大鼠脑IIA(rBIIA)通道不同,宏观钠电流衰减或通道门控的电压依赖性均无明显变化。进一步实验表明,PMA的作用是由PKC激活介导的:(1)无活性的立体异构体4α - PMA无作用;(2)与蛋白激酶抑制剂白屈菜红碱预孵育可防止PMA的作用;(3)可水解的二酰基甘油类似物1 -油酰基 - 2 -乙酰基 -甘油也降低电流(22±5%)。此外,当α1B -肾上腺素能受体与hH1共表达时,α -受体激动剂甲氧明降低hH1电流(45±10%),该作用可通过白屈菜红碱预孵育消除。当被认为负责PKC对rBIIA作用的III - IV结构域间连接区中的保守共有PKC位点(丝氨酸1503)发生突变时,PMA仍降低钠电流,但与野生型通道相比,作用幅度较小。在受体与突变通道共表达后进行α1 -受体刺激时也得到了类似结果。我们得出结论,PKC的激活通过至少两种机制调节人心脏钠通道,一种与大鼠脑通道所见机制类似,涉及一个保守的假定PKC位点,另一种对心脏异构体更具特异性。